UBS Group AG - CERULEAN PHARMA INC ownership

CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105. A total of 37 filers reported holding CERULEAN PHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CERULEAN PHARMA INC
ValueSharesWeighting
Q2 2017$14,000
-17.6%
31,179
+46.4%
0.00%
Q1 2017$17,000
+142.9%
21,295
+118.1%
0.00%
Q4 2016$7,000
+40.0%
9,763
+95.7%
0.00%
Q3 2016$5,000
-58.3%
4,989
-15.3%
0.00%
Q2 2016$12,000
-33.3%
5,887
-14.9%
0.00%
Q1 2016$18,000
+63.6%
6,914
+81.1%
0.00%
Q4 2015$11,000
-21.4%
3,8170.0%0.00%
Q3 2015$14,000
-22.2%
3,8170.0%0.00%
Q2 2015$18,000
-61.7%
3,817
-26.8%
0.00%
Q1 2015$47,000
+261.5%
5,212
+152.2%
0.00%
Q4 2014$13,0002,0670.00%
Other shareholders
CERULEAN PHARMA INC shareholders Q1 2016
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 3,287,529$8,909,0008.51%
Polaris Venture Management Co IV LLC 1,437,441$3,895,0007.33%
Rock Springs Capital Management LP 625,000$1,694,0000.14%
Deer VII & Co. Ltd. 166,675$452,0000.12%
Granahan Investment Management 730,015$1,978,0000.07%
Northeast Financial Consultants Inc 20,000$54,0000.03%
Donald L. Hagan, LLC 3,900$11,0000.01%
Alyeska Investment Group, L.P. 312,809$848,0000.01%
WEDBUSH SECURITIES INC 16,000$43,0000.01%
TFS CAPITAL LLC 15,895$43,0000.01%
View complete list of CERULEAN PHARMA INC shareholders